ArticleRadiation oncology (London, England)2017

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial.

Katrien De Wolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.